HEALTH DECISIONS, INC. - NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE

On Feb 23, 2026, Department of Health and Human Services obligated $1,058,283 to HEALTH DECISIONS, INC. for nichd: r&d: coordination, monitoring, follow-up, evaluation, and completion of a clinical trial of nestorone testosterone gel for male contraception: non-severable. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition after exclusion of sources. Performance is located in DURHAM, NC. The contract is scheduled through Oct 31, 2027 — approximately 16 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.